Rich Wing Email & Phone Number

Foster City, Ca, Us

Team Leadership & Talent Cultivation:• Leader of a team of 8 including 3 direct reports plus 5 dedicated vendor team members• Candid leadership style that emphasizes transparency and accountability, effectively driving performance improvements and operational excellence• Passion for mentorship: building agility, technical proficiency, and stakeholder management skillsStrategic Leadership & Collaboration:• Deliver long-range plan including patient-based forecasting for ARC-10, EVOKE-03, PAC-8, STAR-121, STAR-131, and STAR-221• Innovate novel scenario comparison analytics to inform robust decision making• Execute market research to support LRP, requests for Phase 2 and Phase 3 funding, disease-area strategy, pan-tumor business development, and digital business intelligence platform development• Provide commercial strategy support for Trodelvy (TROP2 ADC), domvanalimab (TIGIT), and zimberelimab (PD1) product strategy teams and business development decisions

Cambridge, Cambridgeshire, Gb

• Spearhead commercial strategy on multiple early and late-stage product teams producing thorough and effective business cases for phase 3 investment• Develop both early and late stage pan-tumor strategy across multiple assets: Imfinzi (PDL1), Enhertu (HER2 ADC), monalizumab (NKG2A), and PD-1 bispecifics: volrustomig (CTLA4), rilvegostomig (TIGIT), and sabestomig (TIM3)• Design and lead the development and launch of a cutting-edge digital infrastructure platform for a company-wide audience resulting in a transformational shift in idea exchange and decision-making

Powell, Ohio, Us

• Managed and led teams of >3 juniors to deliver market research projects for biotech and pharma• Evaluated early stage assets as well as launch benchmarking and patient journey projects• Delivered projects across TAs: CVMD, neurology, oncology, rare disease, and respiratory• Served as the key point of contact for repeat and new clients

New York, New York, Us

• Led 3 direct reports and vendor teams of ~40 people to design Promontory’s valuation model, analyze clinical data, oversee process development, and ensure seamless drug supply chain• Managed Promontory’s alliances with Pfizer, EMD Serono, and SciClone Pharmaceuticals • Oversaw multiple departments as leader of research and operations team reporting to the COO

Bethesda, Md, Us

• Led client presentations and served as a point of contact for clients• Built risk-adjusted valuation models for clients in the pharmaceutical industry• Produced market research projects on early stage (discovery through Phase 2) assets• Covered oncology, autoimmune, CVRM, neurology, and rare disease spaces

New York, Ny, Us

• Led personnel to research the structural basis for transport across the nuclear envelope• Partially funded research via award of NIH F32 grant• Primary techniques included: cloning, heterologous protein expression, protein purification via FPLC, computational modeling, and X-ray crystallography

M.Phil, Ph.D., Molecular Biophysics And Biochemistry

A.B., Summa Cum Laude, Biochemistry

Certificate, Managing Science In The Biotech Industry